Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 12 filings.
15 Jul 2026 3 filings
CG provisions non-applicable
CG provisions not applicable for quarter ended 30 June 2026 due to thresholds.
SME listing on BSE; exemption due to capital ≤ ₹10 crore and net worth ≤ ₹25 crore.
Will comply within six months if regulation becomes applicable in future.
Dematerialisation processing status
Requests for dematerialisation during quarter ended 30/06/2026 were confirmed (accepted/rejected) to the depositories by the RTA.
Securities dematerialised have been listed on the stock exchanges where the earlier issue is listed.
Certificates received for dematerialisation were cancelled after verification, with depositories substituted as registered owner within 15 days.
Lucknow facility operational
Lucknow facility commenced commercial operations; now fully operational.
Facility located at Murli Purwa Khasara No. 923, Deva Road, Lucknow, UP.
Part of expansion to enhance manufacturing capacity, production efficiency, and regional demand.
Expected to improve supply chain, logistics, and timely order fulfillment.
Supports company's long-term growth strategy and North India presence.
Expansion believed to contribute positively to future operations and long-term value.
28 Mar 2026 3 filings
Resignation of Independent Director
Mr. Chand Rameshbhai Kanabar resigned as Independent Director effective March 28, 2026.
Resignation due to personal reasons with no other material cause stated.
He ceased as Chairman of Audit, Nomination & Remuneration, Stakeholders Relationship Committees.
He also ceased membership of the IPO Committee.
Mr. Kanabar holds directorships in other companies including Golden Sparrow Consultancy Pvt Ltd.
No relationships with other directors disclosed.
No disqualification or debarment by SEBI mentioned.
Resignation of Independent Director
Mr. Chand Rameshbhai Kanabar resigned as Independent Director effective March 28, 2026
Resignation due to personal reasons with no other material reasons disclosed
Ceases membership of IPO Committee and chairmanship of Audit, NRC, and SRC committees
Holds directorships in Golden Sparrow Consultancy Pvt Ltd, Accretion Pharmaceuticals Ltd, Curis Lifesciences Ltd
Chairman of Audit, NRC, SRC committees at Golden Sparrow Consultancy Pvt Ltd
Independent Director at Accretion Pharmaceuticals Ltd and Curis Lifesciences Ltd
No regulatory or shareholder approval mentioned as required for resignation
Resignation accepted by the company effective March 28, 2026